Table 3 Inclusion and exclusion criteria for the KBindER study
From: A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia
Inclusion Criteria | Exclusion Criteria |
|---|---|
▪ Plasma K+ ≥ 5.5 mEq/L ▪ Age ≥ 18 years ▪ English or Spanish speaking ▪ Patient able to provide written informed consent | ▪ Recent Bowel Surgery ▪ Ileus or bowel obstruction ▪ Received a dose of an oral potassium binder in past 48 h ▪ Hemolyzed blood specimen as indicated by the laboratory ▪ Severe leukocytosis or thrombocytosis ▪ Pregnancy ▪ Active psychiatric disorder ▪ Diabetic ketoacidosis or hyperkalemia caused by any condition for which a therapy directed against the underlying cause is expected to correct the hyperkalemia ▪ Dialysis session expected within 4 h after randomization ▪ History or hypersensitivity to any of the study drugs ▪ Concurrent use of sorbitol (due to increased risk of intestinal necrosis when used with SPS) |